Gene · 3741
Papers2,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation. | Elife | 2026 | 41569083 | PubTator, text mining | PubMed |
| The Second-Generation Antipsychotic Perospirone Inhibits Voltage-Gated K+ Channels in Coronary Arterial Smooth Muscle Cells. | J Appl Toxicol | 2026 | 40813301 | PubTator, text mining | PubMed |
| p300 upregulates I kur in atrial cardiomyocytes through activating NLRP3 inflammasome in hypertension. | Chin Med J (Engl) | 2026 | 39966999 | PubTator, text mining | PubMed |
| 3-Methyl Glutaconic Aciduria and Elevated Plasma Growth Differentiation Factor 15 Level in an Adult with Monoallelic SPG7 Pathogenic Variant. | Acta Myol | 2025 | 41773441 | PubTator, text mining | PubMed |
| K+ channel blockade limits AF and suppresses phase 3 EADs by slowing repolarization in an electromechanical cell computational model. | Front Physiol | 2025 | 41659927 | PubTator, text mining | PubMed |
| Mapping rare protein-coding variants on multi-organ imaging traits. | Nat Commun | 2025 | 41436735 | PubTator, text mining | PubMed |
| Ion channels and atrial fibrillation: mitophagy as a key mediator. | Front Physiol | 2025 | 41357167 | PubTator, text mining | PubMed |
| RETRACTED: Wu et al. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells. Int. J. Mol. Sci. 2015, 16, 26914-26926. | Int J Mol Sci | 2025 | 41182131 | PubTator, text mining | PubMed |
| Design and synthesis of novel small molecules targeting the Kv1.3 voltage-gated potassium ion channel. | Sci Rep | 2025 | 40993212 | PubTator, text mining | PubMed |
| Duloxetine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle: Electrophysiological evidence and mechanistic insights. | Eur J Pharmacol | 2025 | 40885233 | PubTator, text mining | PubMed |
| Linkage and association of preserved cognitive function in the midwestern Amish at a higher genetic risk of Alzheimer's disease. | Alzheimers Dement | 2025 | 40855969 | PubTator, text mining | PubMed |
| Potential novel diagnostic biomarkers of atrial fibrillation: four ferroptosis-related genes linking immune infiltration. | Eur J Med Res | 2025 | 40855347 | PubTator, text mining | PubMed |
| Identification of marker genes associated with oxidative stress in hypertrophic cardiomyopathy using bioinformatics analysis and experimental validation. | Sci Rep | 2025 | 40770404 | PubTator, text mining | PubMed |
| Gene expression profiling of extraocular muscles in primary inferior oblique overaction. | PeerJ | 2025 | 40452936 | PubTator, text mining | PubMed |
| Exploring Therapeutic Potential of Bi-Qi Capsules in Treatment of Gout by Discovering Crucial Drug Targets. | Pharmaceuticals (Basel) | 2025 | 40430440 | PubTator, text mining | PubMed |
| RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels. | Biomed Pharmacother | 2025 | 40273690 | PubTator, text mining | PubMed |
| SNAP25-dependent membrane trafficking of the Kv1.5 channel regulates the onset of atrial fibrillation. | Nat Commun | 2025 | 40253375 | PubTator, text mining | PubMed |
| The sodium-glucose cotransporter 2 inhibitor tofogliflozin induces vasodilation of rabbit femoral artery by activating Kv channels, the SERCA pump, and the sGC/cGMP pathway. | Eur J Pharmacol | 2025 | 40189081 | PubTator, text mining | PubMed |
| Pericyte Electrical Signalling and Brain Haemodynamics. | Basic Clin Pharmacol Toxicol | 2025 | 40159653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3741/papers?page=2